Evidence map›Paper›PMID 28334685›Full record

ArticleJournal of clinical virology : the official publication of the Pan American Society for Clinical Virology2017

Serum IFN-γ-induced protein 10 (IP-10) as a biomarker for severity of acute respiratory infection in healthy adults.

Mary S Hayney, Kelsey M Henriquez, Jodi H Barnet, Tola Ewers, Heather M Champion, Sean Flannery, Bruce Barrett

Registry-linked trialAbstract read
In one paragraph

Article in Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01654289 (Meditation or Exercise for Preventing Acute Respiratory Infection), which is not on this map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01654289 phase2completednot on this map

Meditation or Exercise for Preventing Acute Respiratory Infection (MEPARI-2)

TypeinterventionalSponsorUniversity of Wisconsin, MadisonRan2012 to 2016Enrolled413ConditionsAcute Respiratory InfectionArmsMindfulness Meditation, Exercise
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it, 80 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Severe COVID-19: what have we learned with the immunopathogenesis?Advances in rheumatology (London, England) · 2020
    Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Journal of thoracic disease · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Mary S HayneySchool of Pharmacy, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States. Electronic address: mary.hayney@wisc.edu.
Kelsey M HenriquezSchool of Pharmacy, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States.
Jodi H BarnetDepartment of Family Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States.
Tola EwersDepartment of Family Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States.
Heather M ChampionSchool of Pharmacy, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States.
Sean FlannerySchool of Pharmacy, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States.
Bruce BarrettDepartment of Family Medicine, University of Wisconsin-Madison, School of Medicine and Public Health, Madison, WI, United States.
University of Wisconsin–Madison · US

Funding

Meditation and Exercise for Preventing Acute Respiratory Infection (MEPARI-2)R01AT006970 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI BARRETT, BRUCE P · 2012 to 2016
$3.7M
Meditation and Exercise for Prevention of Acute Respiratory InfectionR01AT004313 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI BARRETT, BRUCE P · 2009 to 2010
$1.2M
Mentoring and research in patient-oriented medicineK24AT006543 · NCCIH · UNIVERSITY OF WISCONSIN-MADISON · PI BARRETT, BRUCE P · 2012 to 2016
$818k
NCCIH NIH HHS K24 AT006543NCCIH NIH HHS R01 AT004313NCCIH NIH HHS R01 AT006970
6 · The paper itself

Abstract

backgroundThe inflammatory chemokine, interferon-gamma inducible protein of 10kDa (IP-10), is a biomarker associated with several conditions.

objectivesThis study investigated serum concentrations of IP-10 in healthy individuals who developed acute respiratory infection (ARI). The hypothesis is that serum IP-10 concentrations correlate with ARI severity and detection of viral pathogens. STUDY

designData come from a randomized controlled trial measuring the effects of mindfulness meditation or exercise on ARI (Clinical Trials ID: NCT01654289). Healthy adults ages 30-69 were followed for a single season for ARI incidence and severity. This trial is ongoing, and the investigators are still blinded. When a participant reported ARI symptoms, nasal swab and lavage for PCR-based viral identification and blood samples were collected within the first 72h of ARI symptoms. Serum IP-10 concentrations were measured by ELISA (R&D Systems, Inc., Quantikine ELISA, Minneapolis, MN). ARI severity was measured using the validated Wisconsin Upper Respiratory Symptom Survey (WURSS-24) until the ARI episode resolved.

resultsSerum IP-10 concentrations from 225 ARI episodes correlated with ARI global severity (rho 0.28 [95% CI: 0.15-0.39]; p<0.001). IP-10 concentrations were higher with an ARI in which a viral pathogen was detected compared to no viral pathogen detected (median 366pg/ml [IQR: 227-486] vs 163pg/ml [IQR: 127-295], p<0.0001). Influenza infections had higher IP-10 concentrations than coronavirus, enterovirus or rhinovirus, and paramyxovirus.

conclusionSerum IP-10 concentration correlates with ARI global severity. Also, IP-10 concentration measured early in the course of the ARI correlates with the daily severity, duration, and illness symptoms.

Indexed as

Severity of Illness IndexAdultAgedBiomarkersChemokine CXCL10Cohort StudiesEnzyme-Linked Immunosorbent AssayFemaleHumansMaleMiddle AgedRandomized Controlled Trials as TopicRespiratory Tract InfectionsSerumVirus DiseasesBiomarkersChemokine CXCL10CXCL10 protein, humanAcute respiratory infectionBiomarkerHealthy adultsIP-10Viral pathogens

Identifiers

PMID28334685
PMCPMC5408957
OpenAlexW2595775338

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.